Morphoceuticals, Inc. — Form D
Morphoceuticals, Inc. of Medford, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-23. The offering totals $9.8M, of which $9.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-01-23
- Form: D
- Accession: 0000898432-23-000030
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $9.8M
- Amount sold: $9.8M
- Investors: 3
- Date of first sale: 2023-01-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-471540
Issuer
- Name: Morphoceuticals, Inc.
- CIK: 0001962989
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 200 Boston Avenue, Medford, MA, 02155
- Phone: 858-603-2514
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Amy R Kruse | Director | Annapolis, MD |
| David R Gill | Executive Officer | Ramsey, Y8 |
| Michael R Hufford | Executive Officer | Medford, MA |
| David R Kaplan | Promoter | Marblehead, MA |
| Michael R Levin | Promoter | Marblehead, MA |
| Michael R Hufford | Director | Medford, MA |
| Alexander R Pickett | Director | Medford, MA |
| Justin R Briggs | Director | Medford, MA |
| Tamim Hamad JJ Al-Thani | Director | Medford, MA |
| Rosemarie R Hunziker | Director | Medford, MA |
| James Jenson | Director | Medford, MA |
| James Jenson | Executive Officer | Medford, MA |
Other filings by this issuer (1)
More